Antiva Biosciences
Redwood City, CA · Founded 2012 · CIK 0001563355 · Biotech · Private
Topical therapies for HPV-induced pre-cancerous lesions
antivabio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $81M
- 8 Form D · May 2023
- 41 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 1 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $501,006 | |
| Private capital raised | Form D · SEC | $1,100,000 | |
| Private capital raised | Form D · SEC | $1,745,019 | |
| Private capital raised | Form D · SEC | $8,907,483 | |
| Private capital raised | Form D · SEC | $11,140,756 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $15,639,364 | |
| Private capital raised | Form D · SEC | $26,565,771 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2394 | EXARCA PHARMACEUTICALS, LLC | — | — |
| 2395 | Translate Bio | — | $98M |
| 2396 | NeuvaRx, LLC | — | — |
| 2397 | Antiva Biosciences | — | $81M |
| 2398 | Fate Therapeutics | — | $236M |
| 2399 | COLORADO RESEARCH PARTNERS, LLC | — | — |
| 2400 | Halda Therapeutics | — | $198M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kristine BallDirector · Executive Officer
- Keith BleyExecutive Officer
- Michael CannonDirector
- Elaine ChienExecutive Officer
- Oranee DanielsExecutive Officer
- Raju GadirajuExecutive Officer
- Raju Gadiraju, Ph.D.Executive Officer
- Brian GoodmanDirector
- Karl HostetlerDirector · Executive Officer
- Wende HuttonDirector
- Wendee HuttonDirector
- Steven JamesDirector
- Ting JiaDirector
- David KabakoffDirector
- David Kabakoff, Ph.D.Director
- Gail MaderisDirector · Executive Officer
- Vinzenz PloererDirector
- William RespessDirector
- Beni RovinskiDirector
- Benjamin RovinskiDirector
- Clifford SamuelDirector
- John SaywardExecutive Officer
- Florencia SegalDirector
- Michael SullivanExecutive Officer
- Sarah WalterExecutive Officer
- Jenny YipDirector
Patents
- Compositions and Dosage Forms for Treatment of HPV Infection and HPV-Induced Neoplasiaapplication
- Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-induced Neoplasiagranted
- Treatment Of Hpv Infectionapplication
- Treatment Of Hpv-induced Neoplasiaapplication
- Synthesis Of ETHYL-2-((((2-(2-AMINO-6-METHOXY-9H-PURIN-9-YL)-ETHOXY)-METHYL)-(BENZYLOXY)-PHOSPHORYL)-AMINO)-PROPIONATEapplication
- Advantageous Compounds For Treatment Of Hpv Infection And Hpv-induced Neoplasiaapplication
- Device System And Use For Hpv Infection And Cervical Intraepithelial Neoplasiaapplication
- Device System And Use For Hpv Infection And Cervical Intraepithelial Neoplasiaapplication
- Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-induced Neoplasiaapplication
- Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-induced Neoplasiaapplication
- Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-induced Neoplasiaapplication
- Compositions And Dosage Forms For Treatment Of Hpv Infection And Hpv-induced Neoplasiaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.